Myovant Sciences Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about news in Myovant Sciences Ltd..

The service is free and you can unsubscribe at any time.

General | People (37) | Filings (82) | Annual reports (1) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001679082

Myovant Sciences Ltd. is a publicly traded company

Trading symbol: MYOV

News

2017-09-21

Shares Running on Volume: Myovant Sciences Ltd (MYOV)
The Business Union
Shares of Myovant Sciences Ltd (MYOV) is moving on volatility today -5.58% or -0.72 from the open. The NYSE listed company saw a recent bid of 12.18 on 24424 volume.

2017-09-19

Favorable Media Coverage Somewhat Unlikely to Impact Myovant Sciences (MYOV ...
Dispatch Tribunal
Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders.
Myovant Sciences Ltd (MYOV) Upgraded at Zacks Investment Research - Week Herald

2017-09-17

Myovant Sciences Ltd (NASDAQ:MYOV) Upgraded at Zacks Investment Research
Dispatch Tribunal
Myovant Sciences Ltd (NASDAQ:MYOV) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Thursday, September 7th.
Zacks Investment Research downgraded Myovant Sciences Ltd (NASDAQ:MYOV) to ... - Breaking Finance News

2017-09-14

Form 3 Myovant Sciences Ltd. For: Sep 06 Filed by: SVF GP (Jersey) Ltd
StreetInsider.com
1. The Reporting Persons (as defined below) do not directly own any common shares (the "Common Shares") of Myovant Sciences Ltd. (the "Issuer"). The Reporting Persons acquired Roivant Sciences Ltd. ("Roivant") common shares on September 6, 2017.

2017-09-14

Myovant Sciences Ltd (NASDAQ:MYOV) Stock Rating Upgraded by Zacks Investment ...
TrueBlueTribune
Myovant Sciences Ltd (NASDAQ:MYOV) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday, September 7th.
Signal Watch: Percentage Price Oscillator is Below the Signal for Myovant ... - Rives Journal

2017-09-12

Myovant Sciences (MYOV) Getting Favorable Press Coverage, Report Shows
Dispatch Tribunal
Myovant Sciences logo Media coverage about Myovant Sciences (NASDAQ:MYOV) has been trending positive on Tuesday, Accern reports. Accern rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time ...

2017-09-09

Myovant Sciences Ltd (MYOV) Receives $19.50 Consensus PT from Analysts
The Ledger Gazette
Myovant Sciences logo Myovant Sciences Ltd (NASDAQ:MYOV) has been given a consensus rating of “Buy” by the seven ratings firms that are currently covering the company, Marketbeat.
Zacks Investment Research Upgrades Myovant Sciences Ltd (MYOV) to Hold - StockNewsTimes
Myovant Sciences Ltd (NASDAQ:MYOV) Upgraded to “Hold” at Zacks Investment Research - Week Herald

Myovant Sciences Ltd. address

20-22 BEDFORD ROW
LONDON
WC1R 4JS

Earliest known filing

July 2016

Latest known filing

September 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

Myovant Sciences Ltd. has 82 filings. View Myovant Sciences Ltd. filings.

Annual Reports

Quarterly Reports

Latest company events

People

We have found 37 people related to Myovant Sciences Ltd..